White House Credits Trump With Overdose Plunge That Began Under Biden
Researchers point to CDC data showing a 39-month decline, contradicting administration claims that gains arrived only in the last 18 months.
By Julia Wang ·

The White House claims President Trump's policies caused a dramatic drop in U.S. drug overdose deaths, but leading researchers say the trend began well before he took office. Officials at the Office of National Drug Control Policy cited new Centers for Disease Control and Prevention data showing deaths have fallen to their lowest level in roughly a decade. The administration argues this saves nearly 50,000 lives annually and represents a 41.5% decrease from the peak under the previous administration.
Sara Carter, the ONDCP director, stated that the decline proves America is unequivocally winning the fight against illicit drugs. She attributed the success to heightened border security and the dismantling of narco-terrorist organizations. Carter insisted these gains occurred primarily over the last 18 months due to policies enacted under Trump's leadership. The White House statement did not mention that the downward trajectory started years earlier.
CDC data indicates that reductions in drug deaths began in 2023. The decline has continued for at least 39 consecutive months, not the 18 months cited by the ONDCP. By the time President Biden left office, fatal overdoses had already dropped by roughly one-third. Addiction experts described this improvement as unprecedented at the time.
Nabarun Dasgupta, a street drug researcher at the University of North Carolina at Chapel Hill, noted that the trend toward fewer deaths began in some regions as early as 2021. He said the period from early 2024 through spring 2025 saw the greatest rate of decline ever recorded. Dasgupta was among the first scientists to detect the drop in overdose fatalities.
Fentanyl overdoses spiked sharply during the first two years of the Biden presidency. The surge in fentanyl deaths began in 2013 during the Obama administration and accelerated during Trump's first term. Despite the recent decline, fentanyl remains the leading cause of drug deaths nationwide.
Researchers credit the Biden administration with rolling out policy responses that contributed to the decline. These measures included wider access to healthcare and making naloxone more readily available. The administration also negotiated a deal with China to disrupt the flow of industrial chemicals used to make fentanyl. Felbab-Brown of the Brookings Institution noted that important efforts to crack down on Mexican cartels began during that period.
Carter responded to the earlier timeline by arguing that the Biden administration does not get credit for overseeing the highest drug overdose numbers in history. She stated that bringing those numbers down from their own failure is not progress. Carter added that the Trump administration is positioned to build on the reductions made over the last three years by maintaining border security.
Vanda Felbab-Brown, a drug policy expert at the Brookings Institution, said she does not share the administration's confidence regarding the dismantling of narco-terrorist organizations. She said she cannot think of one such organization that has been dismantled. She noted that they all continue operating and smuggling drugs. Military experts have also questioned the effectiveness and legality of Trump's strikes on vessels described as smuggling boats.
Dasgupta expressed concern about sustaining progress as the Trump administration implements deep cuts to Medicaid passed by the Republican Congress. The Congressional Budget Office estimates the cuts could mean as many as 10 million Americans losing health insurance coverage. Dasgupta stated that Medicaid is the largest funder of addiction services in the United States.






